gvtcx

Generic Anti Infective Drugs

key details

Value£6,519,533
Statuscomplete
Category (CPV) 33600000
RegionWales
Deadline16 Aug 2021
Procedureopen
OCIDocds-h6vhtk-02c945

Awards (26)

This procurement was awarded to 26 suppliers. Values shown are per-award; the notice total is £6,519,533.

SupplierValueDateStatus
Accord-UK shared · · active
Baxter Healthcare shared · · active
Bowmed Ibisqus shared · · active
Crescent Pharma shared · · active
Flynn Pharma shared · · active
Focus Pharmaceuticals shared · · active
Fresenius Kabi shared · · active
Glaxo Smithkline shared · · active
Intrapharm Labs shared · · active
Kent Pharmaceuticals shared · · active
Martindale shared · · active
Merck Sharp & Dohme shared · · active
Mercury Pharmaceuticals shared · · active
Milpharm shared · · active
Morningside Pharmaceuticals shared · · active
Mylan shared · · active
Neon Healthcare shared · · active
Pfizer shared · · active
Ranbaxy shared · · active
RPH Pharmaceuticals shared · · active
Sandoz shared · · active
Selective Supplies shared · · active
Teva shared · · active
Torrent Pharmaceuticals shared · · active
Wockhardt shared · · active
Zentiva shared · · active

description

Generic Anti Infective Drugs

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
16 Jul 2021 Contract notice (F02) Earlier regulations 016851-2021
16 Mar 2022 Contract award notice (F03) Earlier regulations 007264-2022

more from Velindre NHS Trust, NHS Wales Shared Services Parternship - Procurement Services (On Behalf of All Wales) Health Boards and Trusts

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.